{"transactions":[{"id":743626,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T00:00:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":328833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 19, 2025 and was subject to a performance-based vesting condition that was satisfied on June 10, 2026. The option will vest as to 1/36 on July 31, 2026, with the remaining options vesting in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuing service on each such vesting date."}],"balance_after":328833,"derivative":{"exercise_price":1.65,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":328833},"source":{"system":"sec-edgar","filing":"0001193125-26-266277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526266277/ownership.xml","form_type":"4"}},{"id":787312,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":260946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests as follows: (i) as to 1,736,275 shares, vested 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; (ii) as to 612,245 shares, vested 1/36 on January 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; and (iii) as to 1,248,570 shares, vested 1/36 on March 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":3336144,"derivative":{"exercise_price":0.15,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":260946},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787311,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:53:53.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787310,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":3597090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests as follows: (i) as to 1,736,275 shares, vested 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; (ii) as to 612,245 shares, vested 1/36 on January 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; and (iii) as to 1,248,570 shares, vested 1/36 on March 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":3597090,"derivative":{"exercise_price":0.15,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":3597090},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787309,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":42790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":42790},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787308,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option was granted on August 23, 2023 and was scheduled to vest subject to certain performance criteria, which the Board waived in connection with the exercise."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787307,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":68700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter.  The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":68700},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787306,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":60390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":60390},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787305,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":68700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reporting person agreed to cancellation of an option granted to him on January 25, 2023 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter.  The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":68700,"derivative":{"exercise_price":0.0001,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":68700},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787304,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":68700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reporting person agreed to cancellation of an option granted to him on January 25, 2023 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter.  The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":0,"derivative":{"exercise_price":4.27,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":68700},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787303,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":24810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted to him on May 18, 2021 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":24810,"derivative":{"exercise_price":0.0001,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":24810},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787302,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24810,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted to him on May 18, 2021 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.41,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":24810},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787301,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":35580,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted to him on April 1, 2021 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":35580,"derivative":{"exercise_price":0.0001,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":35580},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787300,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35580,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted to him on April 1, 2021 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.36,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":35580},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787299,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":42790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on February 6, 2022 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":42790,"derivative":{"exercise_price":0.0001,"expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":42790},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787298,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2024-10-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42790,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on February 6, 2022 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":0,"derivative":{"exercise_price":18.4,"expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":42790},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787297,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:53:53.000Z","date":"2022-02-06","kind":"grant","planned":false,"acquired":true,"shares":42790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise."}],"balance_after":42790,"derivative":{"exercise_price":18.4,"expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":42790},"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787296,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-08T20:53:53.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":260946,"price":0.15,"value":39141.9,"ownership":{"direct":true},"balance_after":1672756,"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787295,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-08T20:53:53.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1411810,"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787294,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-08T20:53:53.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") that was fully vested upon grant."}],"balance_after":1396810,"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":787293,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-08T20:53:53.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":196880,"price":0.0001,"value":19.688,"ownership":{"direct":true},"balance_after":396810,"source":{"system":"sec-edgar","filing":"0001193125-26-214890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214890/ownership.xml","form_type":"4"}},{"id":1293352,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-28T22:37:18.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-25-006784","document":"tm254730-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006784/tm254730-4_4seq1.xml","form_type":"4"}},{"id":1293351,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-28T22:37:18.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":199930,"source":{"system":"sec-edgar","filing":"0001104659-25-006784","document":"tm254730-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006784/tm254730-4_4seq1.xml","form_type":"4"}},{"id":1385137,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-17T20:01:12.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award was made under the Issuer's 2018 Equity Incentive Plan and vests as to 25% on October 16, 2025 and in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":169930,"source":{"system":"sec-edgar","filing":"0001104659-24-109519","document":"tm2426349-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924109519/tm2426349-2_4seq1.xml","form_type":"4"}},{"id":1669873,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:32:14.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-007290","document":"tm244260-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924007290/tm244260-1_4seq1.xml","form_type":"4"}},{"id":2043940,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-27T21:04:02.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":68700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":68700,"derivative":{"exercise_price":4.27,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":68700},"source":{"system":"sec-edgar","filing":"0001104659-23-007511","document":"tm234565-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923007511/tm234565-2_4seq1.xml","form_type":"4"}},{"id":2486681,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2021-12-03T22:15:25.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":279158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":279158},"source":{"system":"sec-edgar","filing":"0001415889-21-005693","document":"form4-12032021_021217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005693/form4-12032021_021217.xml","form_type":"4"}},{"id":2486680,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-12-03T22:15:25.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":81933,"price":0.72,"value":58991.76,"ownership":{"direct":true},"balance_after":197225,"source":{"system":"sec-edgar","filing":"0001415889-21-005693","document":"form4-12032021_021217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005693/form4-12032021_021217.xml","form_type":"4"}},{"id":2486679,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-12-03T22:15:25.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":279158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."}],"balance_after":279158,"source":{"system":"sec-edgar","filing":"0001415889-21-005693","document":"form4-12032021_021217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005693/form4-12032021_021217.xml","form_type":"4"}},{"id":2708657,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-18T21:45:58.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":992409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan in accordance with the anti-dilution provisions of the Reporting Person's employment agreement in connection with a Qualifying Financing as defined therein. The stock options vest and become exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter, subject to Reporting Person's continued employment or other service with the Issuer on each applicable vesting date, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction."}],"balance_after":992409,"derivative":{"exercise_price":1.41,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":992409},"source":{"system":"sec-edgar","filing":"0001415889-21-002554","document":"form4-05182021_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002554/form4-05182021_050501.xml","form_type":"4"}},{"id":2762107,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-03T00:55:37.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":1423238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The stock  options vest and become exercisable over a four-year period, with one-fourth of the Issuer's shares of common stock underlying the options vesting on April 1, 2022, and with the remainder vesting in twelve equal quarterly installments thereafter, subject to Reporting Person's continued employment or other service  with the Issuer on each applicable vesting date, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction."}],"balance_after":1423238,"derivative":{"exercise_price":3.36,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1423238},"source":{"system":"sec-edgar","filing":"0001415889-21-001848","document":"form4-04022021_050420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001848/form4-04022021_050420.xml","form_type":"4"}},{"id":2762106,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2021-04-03T00:55:37.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":55854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."}],"balance_after":279158,"derivative":{"underlying":"Common Stock","underlying_shares":55854},"source":{"system":"sec-edgar","filing":"0001415889-21-001848","document":"form4-04022021_050420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001848/form4-04022021_050420.xml","form_type":"4"}},{"id":2762105,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39772,"kind":"person","name":"Aggarwal Sumit","position":1,"cik":"0001854362","reported_name":"Aggarwal Sumit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2021-04-03T00:55:37.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":223304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."}],"balance_after":223304,"derivative":{"underlying":"Common Stock","underlying_shares":223304},"source":{"system":"sec-edgar","filing":"0001415889-21-001848","document":"form4-04022021_050420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001848/form4-04022021_050420.xml","form_type":"4"}}]}